161 related articles for article (PubMed ID: 29355754)
1. Blocking mutation independent p53 aggregation by emodin modulates autophagic cell death pathway in lung cancer.
Haque E; Kamil M; Irfan S; Sheikh S; Hasan A; Nazir A; Mir SS
Int J Biochem Cell Biol; 2018 Mar; 96():90-95. PubMed ID: 29355754
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53.
Kamil M; Haque E; Mir SS; Irfan S; Hasan A; Sheikh S; Alam S; Ansari KM; Nazir A
Anticancer Agents Med Chem; 2019; 19(2):184-193. PubMed ID: 30370860
[TBL] [Abstract][Full Text] [Related]
3. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells.
Lai JM; Chang JT; Wen CL; Hsu SL
Eur J Pharmacol; 2009 Nov; 623(1-3):1-9. PubMed ID: 19744477
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol modulates the apoptosis and autophagic death of human lung adenocarcinoma A549 cells via a p53‑dependent pathway: Integrated bioinformatics analysis and experimental validation.
Fan Y; Li J; Yang Y; Zhao X; Liu Y; Jiang Y; Zhou L; Feng Y; Yu Y; Cheng Y
Int J Oncol; 2020 Oct; 57(4):925-938. PubMed ID: 32945383
[TBL] [Abstract][Full Text] [Related]
5. Autophagy augments the self-renewal of lung cancer stem cells by the degradation of ubiquitinated p53.
Wang J; Liu D; Sun Z; Ye T; Li J; Zeng B; Zhao Q; Rosie Xing H
Cell Death Dis; 2021 Jan; 12(1):98. PubMed ID: 33468994
[TBL] [Abstract][Full Text] [Related]
6. The Lys-Specific Molecular Tweezer, CLR01, Modulates Aggregation of the Mutant p53 DNA Binding Domain and Inhibits Its Toxicity.
Herzog G; Shmueli MD; Levy L; Engel L; Gazit E; Klärner FG; Schrader T; Bitan G; Segal D
Biochemistry; 2015 Jun; 54(24):3729-38. PubMed ID: 26030124
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
[TBL] [Abstract][Full Text] [Related]
8. PRIMA-1 induces autophagy in cancer cells carrying mutant or wild type p53.
Russo D; Ottaggio L; Foggetti G; Masini M; Masiello P; Fronza G; Menichini P
Biochim Biophys Acta; 2013 Aug; 1833(8):1904-13. PubMed ID: 23545415
[TBL] [Abstract][Full Text] [Related]
9. Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells.
Su YJ; Tsai MS; Kuo YH; Chiu YF; Cheng CM; Lin ST; Lin YW
Mol Pharmacol; 2010 Apr; 77(4):633-43. PubMed ID: 20042515
[TBL] [Abstract][Full Text] [Related]
10. Aloin promotes A549 cell apoptosis via the reactive oxygen species‑mitogen activated protein kinase signaling pathway and p53 phosphorylation.
Wan L; Zhang L; Fan K; Wang J
Mol Med Rep; 2017 Nov; 16(5):5759-5768. PubMed ID: 28901386
[TBL] [Abstract][Full Text] [Related]
11. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
12. High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.
Kuo WT; Tu DG; Chiu LY; Sheu GT; Wu MF
Oncol Rep; 2017 Nov; 38(5):2787-2795. PubMed ID: 28901493
[TBL] [Abstract][Full Text] [Related]
13. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
Li J; JunYu ; Liu A; Wang Y
Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors.
Zhu Y; Sun W; Jiang X; Bai R; Luo Y; Gao Y; Li S; Huang Z; Gong Y; Xie C
PLoS One; 2023; 18(1):e0281132. PubMed ID: 36706151
[TBL] [Abstract][Full Text] [Related]
15. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
16. Polyarginine and its analogues inhibit p53 mutant aggregation and cancer cell proliferation in vitro.
Chen Z; Chen J; Keshamouni VG; Kanapathipillai M
Biochem Biophys Res Commun; 2017 Jul; 489(2):130-134. PubMed ID: 28536076
[TBL] [Abstract][Full Text] [Related]
17. Loss of mutant p53 in HaCaT keratinocytes promotes cadmium-induced keratin 17 expression and cell death.
Romashin D; Rusanov A; Tolstova T; Varshaver A; Netrusov A; Kozhin P; Luzgina N
Biochem Biophys Res Commun; 2024 May; 709():149834. PubMed ID: 38547608
[TBL] [Abstract][Full Text] [Related]
18. A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089.
Sharma K; Goehe RW; Di X; Hicks MA; Torti SV; Torti FM; Harada H; Gewirtz DA
Autophagy; 2014; 10(12):2346-61. PubMed ID: 25629933
[TBL] [Abstract][Full Text] [Related]
19. p53 protein aggregation promotes platinum resistance in ovarian cancer.
Yang-Hartwich Y; Soteras MG; Lin ZP; Holmberg J; Sumi N; Craveiro V; Liang M; Romanoff E; Bingham J; Garofalo F; Alvero A; Mor G
Oncogene; 2015 Jul; 34(27):3605-16. PubMed ID: 25263447
[TBL] [Abstract][Full Text] [Related]
20. Integration of bioinformatics and experiments to identify TP53 as a potential target in Emodin inhibiting diffuse large B cell lymphoma.
Chen Y; Mei X; Gan D; Wu Z; Cao Y; Lin M; Zhang N; Yang T; Chen Y; Hu J
Biomed Pharmacother; 2018 Nov; 107():226-233. PubMed ID: 30096626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
